168542-76-5

Basic information

• Product Name: N-(cyanomethyl)-N-methyl-3-(4-methylbenzoyl)-2-pyridinecarboxamide
• Synonyms: N-(cyanomethyl)-N-methyl-3-(4-methylbenzoyl)-2-pyridinecarboxamide
• CAS NO: 168542-76-5
• Molecular Weight: 293.325
• Mol File: 168542-76-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-(cyanomethyl)-N-methyl-3-(4-methylbenzoyl)-2-pyridinecarboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(cyanomethyl)-N-methyl-3-(4-methylbenzoyl)-2-pyridinecarboxamide(168542-76-5)
• EPA Substance Registry System: N-(cyanomethyl)-N-methyl-3-(4-methylbenzoyl)-2-pyridinecarboxamide(168542-76-5)

Safety Data

• Hazardous Substances Data: 168542-76-5(Hazardous Substances Data)

Upstream product

• 508210-05-7 3-p-toluoyl-pyridine-2-carbonyl chloride 
• 25808-30-4 2-(methylamino)acetonitrile hydrochloride 
• 116060-91-4 3-(4-methylbenzoyl)-2-pyridine carboxylic acid 
• 108-88-3 toluene 
• 699-98-9 Pyridine-2,3-dicarboxylic anhydride 

Downstream Products

• 170640-09-2 7,8-dihydro-7-methyl-5-(4-methylphenyl)-8-oxo-1,7-naphthyridine-6-carboxylic acid 
• 168542-78-7 7,8-dihydro-7-methyl-5-(4-methylphenyl)-8-oxo-6-pyrido<3,4-b>pyridinecarboxamide 
• 168542-77-6 7,8-dihydro-7-methyl-5-(4-methylphenyl)-8-oxo-6-pyrido<3,4-b>pyridinecarbonitrile 

Relevant articles and documents

Heterocyclic compounds, their production and use as tachykinin reactor antagonists

A novel compound represented by the formula: STR1 wherein Ring A and Ring B respectively stands for an optionally substituted homo- or hetero-cyclic ring, and at least one of them stands for an optionally substituted heterocyclic ring stand; Ring C stands for an optionally substituted benzene ring; R stands for a hydrogen atom or an optionally substituted hydrocarbon residue; one of X and Y stands for --NR1 -- (R1 stands for a hydrogen atom or an optionally substituted hydrocarbon residue) or --O--, and the other stands for--CO-- or --CS--, or one of them stands for --N= and the other stands for =CR2 -- (R2 stands for a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon residue, an optionally substituted amino group or an optionally substituted hydroxyl group); n denotes 1 or 2 or salts thereof which have an excellent tachykinin receptor antagonistic action and inhibitory action on plasma extravasation.